This mechanism is distinct from growth hormone secretagogues, incretin mimetics, or direct receptor agonistsmeaning AHK-Cu doesn't compete for the same binding sites as GLP-1 analogs, growth hormone releasing peptides, or melanocortin receptor targets
These are not direct pharmacological effects of the medication
[1] [3] Some users report subjective improvement in energy levels with sublingual B12, though this may reflect placebo effects or the psychological benefit of a different administration route
Members experience the clearest wins when the choice is framed by outcome, not by chemistry
Evidence is insufficient for weight loss (failed Phase 2b trial) and preliminary for osteoarthritis (small open-label studies without adequate controls)
Itching may show up as: Vaginal or vulvar itching Dry, itchy, or crawly skin Increased sensitivity to soaps or fabrics The British Menopause Society describes this under genitourinary syndrome of menopause (GSM): GSM consensus statement (BMS)